rs10771973

Variant names:

• chr12-32640040-G-A
• rs10771973
• NM_001370298.3:c.2455-236G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_Strong BP6_Moderate BA1

The NM_001370298.3(FGD4):​c.2455-236G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.27 in 151,970 control chromosomes in the GnomAD database, including 5,874 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

• Frequency: Genomes: 𝑓 0.27 (5874 hom., cov: 31)
• Consequence: FGD4 NM_001370298.3 intron
• Clinical Significance: Benign criteria provided, single submitter B:1
• Conservation: PhyloP100: -0.615
• Publications: 31 publications found

Genes affected

FGD4 (HGNC:19125): (FYVE, RhoGEF and PH domain containing 4) This gene encodes a protein that is involved in the regulation of the actin cytoskeleton and cell shape. This protein contains an actin filament-binding domain, which together with its Dbl homology domain and one of its pleckstrin homology domains, can form microspikes. This protein can activate MAPK8 independently of the actin filament-binding domain, and it is also involved in the activation of CDC42 via the exchange of bound GDP for free GTP. The activation of CDC42 also enables this protein to play a role in mediating the cellular invasion of Cryptosporidium parvum, an intracellular parasite that infects the gastrointestinal tract. Mutations in this gene can cause Charcot-Marie-Tooth disease type 4H (CMT4H), a disorder of the peripheral nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2015]

FGD4 Gene-Disease associations (from GenCC):

• Charcot-Marie-Tooth disease

  Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
• Charcot-Marie-Tooth disease type 4H

  Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

ACMG classification

Our verdict: Benign. The variant received -14 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.91).
• BP6: Variant 12-32640040-G-A is Benign according to our data. Variant chr12-32640040-G-A is described in ClinVar as Benign. ClinVar VariationId is 680175.Status of the report is criteria_provided_single_submitter, 1 stars.
• BA1: GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.403 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001370298.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	FGD4	NM_001370298.3	MANE Select	c.2455-236G>A		intron	N/A	NP_001357227.2
	FGD4	NM_001384126.1		c.2455-236G>A		intron	N/A	NP_001371055.1
	FGD4	NM_001304481.2		c.2299-236G>A		intron	N/A	NP_001291410.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	FGD4	ENST00000534526.7	TSL:5 MANE Select	c.2455-236G>A		intron	N/A	ENSP00000449273.1
	FGD4	ENST00000531134.7	TSL:2	c.2299-236G>A		intron	N/A	ENSP00000431323.1
	FGD4	ENST00000427716.7	TSL:2	c.2044-236G>A		intron	N/A	ENSP00000394487.2

Frequencies

GnomAD3 genomes AF: 0.270 AC: 40977 AN: 151852 Hom.: 5872 Cov.: 31

Gnomad AFR AF: 0.186

Gnomad AMI AF: 0.469

Gnomad AMR AF: 0.290

Gnomad ASJ AF: 0.386

Gnomad EAS AF: 0.177

Gnomad SAS AF: 0.417

Gnomad FIN AF: 0.226

Gnomad MID AF: 0.373

Gnomad NFE AF: 0.309

Gnomad OTH AF: 0.312

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.270 AC: 40979 AN: 151970 Hom.: 5874 Cov.: 31 AF XY: 0.270 AC XY: 20065 AN XY: 74260

African (AFR) AF: 0.186 AC: 7707 AN: 41446

American (AMR) AF: 0.289 AC: 4414 AN: 15262

Ashkenazi Jewish (ASJ) AF: 0.386 AC: 1340 AN: 3470

East Asian (EAS) AF: 0.176 AC: 907 AN: 5142

South Asian (SAS) AF: 0.418 AC: 2010 AN: 4812

European-Finnish (FIN) AF: 0.226 AC: 2383 AN: 10550

Middle Eastern (MID) AF: 0.374 AC: 110 AN: 294

European-Non Finnish (NFE) AF: 0.309 AC: 21029 AN: 67972

Other (OTH) AF: 0.309 AC: 651 AN: 2110

Alfa AF: 0.294 Hom.: 13893

Bravo AF: 0.268

Asia WGS AF: 0.302 AC: 1051 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

not provided Benign:1

Jun 14, 2018

GeneDx

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.91
CADD	Benign	1.0
DANN	Benign	0.45
PhyloP100		-0.61
Mutation Taster		=100/0	polymorphism (auto)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs10771973; hg19: chr12-32792974;